Gene Therapies Make A Mark In US FDA Expedited Review Programs

More than 20 gene therapies are being developed with increased interaction under FDA’s breakthrough and regenerative medicine programs. 

Researcher working with DNA on blurred background.

More from Review Pathways

More from Pathways & Standards